Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy

The present study aimed to investigate the impact of pre-treatment C-reactive protein (CRP) levels on the prediction of prognosis in patients with metastatic renal cell carcinoma (mRCC), who were classified as intermediate-risk patients using the Memorial Sloan Kettering Cancer Center (MSKCC) risk c...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: TEISHIMA, JUN, KOBATAKE, KOHEI, HAYASHI, TETSUTARO, SENO, YASUYUKI, IKEDA, KENICHIRO, NAGAMATSU, HIROTAKA, HIEDA, KEISUKE, SHOJI, KOICHI, MIYAMOTO, KATSUTOSHI, INOUE, SHOGO, KOBAYASHI, KANAO, OHARA, SHINYA, KAJIWARA, MITSURU, MATSUBARA, AKIO
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: D.A. Spandidos 2014
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4081304/
https://ncbi.nlm.nih.gov/pubmed/25013512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2014.2207
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg